{"transactions":[{"id":2347954,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"officer_title":"President, CEO & CFO"}}],"security":"Warrants (right to buy)","published_at":"2022-03-07T17:44:41.000Z","date":"2022-03-05","kind":"exercise","acquired":false,"shares":14815,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.7,"exercise_date":"2017-03-17","expiration_date":"2022-03-17","underlying":"Common Stock","underlying_shares":14815},"source":{"system":"sec-edgar","filing":"0001437749-22-005408","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000143774922005408/rdgdoc.xml","form_type":"4"}},{"id":2347953,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"officer_title":"President, CEO & CFO"}}],"security":"Common Stock","published_at":"2022-03-07T17:44:41.000Z","date":"2022-03-05","kind":"exercise","acquired":true,"shares":14815,"price":2.7,"value":40000.5,"ownership":{"direct":true},"balance_after":92773,"source":{"system":"sec-edgar","filing":"0001437749-22-005408","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000143774922005408/rdgdoc.xml","form_type":"4"}},{"id":2469931,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-16T21:16:03.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":38612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On 12/14/21, the Reporting Person was granted an option to purchase 38,612 shares of common stock of the Company. Options to purchase 9,653 shares vest on 12/14/22 and options to purchase 28,959 shares vest quarterly in 12 equal amounts commencing on 3/14/23."}],"balance_after":38612,"derivative":{"exercise_price":6.82,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":38612},"source":{"system":"sec-edgar","filing":"0001437749-21-028832","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000143774921028832/rdgdoc.xml","form_type":"4"}},{"id":2597972,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-08-18T18:08:02.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":2500,"price":7.7733,"value":19433.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.60 to $7.85. The reporting person undertakes to provide the Company, any security holder of the Company. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":77958,"source":{"system":"sec-edgar","filing":"0000914190-21-000282","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419021000282/edgar.xml","form_type":"4"}},{"id":2597971,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-08-18T18:08:02.000Z","date":"2021-08-17","kind":"purchase","acquired":true,"shares":2500,"price":7.6687,"value":19171.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.66 to $7.6699. The reporting person undertakes to provide the Company, any security holder of the Company. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":75458,"source":{"system":"sec-edgar","filing":"0000914190-21-000282","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419021000282/edgar.xml","form_type":"4"}},{"id":2973242,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-11-19T18:17:34.000Z","date":"2020-11-19","kind":"purchase","acquired":true,"shares":1000,"price":5.8669,"value":5866.9,"ownership":{"direct":true},"balance_after":72958,"source":{"system":"sec-edgar","filing":"0000914190-20-000420","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419020000420/edgar.xml","form_type":"4"}},{"id":3046440,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President/CEO/CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-26T16:33:52.000Z","date":"2020-08-24","kind":"grant","acquired":true,"shares":152064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On 8/24/20, the Reporting Person was granted an option to purchase 152,064 shares of common stock of the Company.  Options to purchase 38,016 shares vest on 8/24/21 and options to purchase 114,048 shares vest quarterly in 12 equal amounts commencing on 11/24/21."}],"balance_after":152064,"derivative":{"exercise_price":7.07,"expiration_date":"2030-08-24","underlying":"Common Stock","underlying_shares":152064},"source":{"system":"sec-edgar","filing":"0000914190-20-000355","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419020000355/edgar.xml","form_type":"4"}},{"id":3052499,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO/CFO"}}],"security":"Common Stock","published_at":"2020-08-19T18:22:45.000Z","date":"2020-08-19","kind":"purchase","acquired":true,"shares":950,"price":7.4,"value":7030.0,"ownership":{"direct":true},"balance_after":71958,"source":{"system":"sec-edgar","filing":"0000914190-20-000331","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419020000331/edgar.xml","form_type":"4"}},{"id":3130727,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Common Stock","published_at":"2020-05-29T18:08:31.000Z","date":"2020-05-28","kind":"purchase","acquired":true,"shares":1000,"price":6.96,"value":6960.0,"ownership":{"direct":true},"balance_after":71008,"source":{"system":"sec-edgar","filing":"0000914190-20-000192","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419020000192/edgar.xml","form_type":"4"}},{"id":3213654,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Common Stock","published_at":"2020-03-12T16:50:33.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":1000,"price":6.7,"value":6700.0,"ownership":{"direct":true},"balance_after":70008,"source":{"system":"sec-edgar","filing":"0000914190-20-000112","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419020000112/edgar.xml","form_type":"4"}},{"id":3224664,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Common Stock","published_at":"2020-03-05T17:10:10.000Z","date":"2020-03-05","kind":"purchase","acquired":true,"shares":700,"price":8.4567,"value":5919.69,"ownership":{"direct":true},"balance_after":69008,"source":{"system":"sec-edgar","filing":"0000914190-20-000105","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419020000105/edgar.xml","form_type":"4"}},{"id":3288832,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-05T17:14:18.000Z","date":"2020-02-01","kind":"grant","acquired":true,"shares":13958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On 5/1/17, the Reporting Person was granted an option to purchase up to 46,525 shares of common stock of the Company. Options to purchase 5,815 shares vested on 5/1/18; options to purchase 17,447 shares vest quarterly in 12 equal amounts commencing on 7/1/18; options to purchase 4,653 shares will vest, if ever, on 2/1 following the Company's first completed fiscal year in which annual revenue exceeds $6,000,000; options to purchase 9,305 shares will vest, if ever, on 2/1 following the Company's first completed fiscal year in which annual revenue exceeds $10,000,000; and options to purchase 9,305 shares vested upon approval of listing of the Company's common stock on the Nasdaq Stock Market. The Company achieved both the $6,000,000 and $10,000,000 annual revenue milestones in fiscal year 2019 and 13,958 shares vested on 2/1/20."}],"balance_after":46525,"derivative":{"exercise_price":2.64,"expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":13958},"source":{"system":"sec-edgar","filing":"0000914190-20-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419020000042/edgar.xml","form_type":"4"}},{"id":3288831,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-05T17:14:18.000Z","date":"2020-02-01","kind":"grant","acquired":true,"shares":19320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On 2/13/17, the Reporting Person was granted an option to purchase up to 64,399 shares of common stock of the Company. Options to purchase 8,049 shares vested on 2/13/18; options to purchase 24,150 shares vest quarterly in 12 equal amounts commencing on 5/13/18; options to purchase 12,880 shares vested upon approval of listing of the Company's common stock on the Nasdaq Stock Market; options to purchase 6,440 shares will vest, if ever, on 2/1 following the Company's first completed fiscal year in which annual revenue exceeds $6,000,000; and options to purchase 12,880 shares will vest, if ever, on 2/1 following the Company's first completed fiscal year in which annual revenue exceeds $10,000,000. The Company achieved both the $6,000,000 and $10,000,000 annual revenue milestones in fiscal year 2019 and 19,320 shares vested on 2/1/20."}],"balance_after":64399,"derivative":{"exercise_price":4.14,"expiration_date":"2027-02-13","underlying":"Common Stock","underlying_shares":19320},"source":{"system":"sec-edgar","filing":"0000914190-20-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419020000042/edgar.xml","form_type":"4"}},{"id":3337022,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Stock Option (right to  buy)","published_at":"2019-12-18T17:14:37.000Z","date":"2019-12-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On 12/16/19, the Reporting Person was granted an option to purchase 20,000 shares of common stock of the Company.  Options to purchase 5,000 shares vest on 12/16/20 and options to purchase 15,000 shares vest quarterly in 12 equal amounts commencing on 3/16/21."}],"balance_after":20000,"derivative":{"exercise_price":8.3,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000914190-19-000510","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419019000510/edgar.xml","form_type":"4"}},{"id":3337021,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Common Stock","published_at":"2019-12-18T17:14:37.000Z","date":"2019-12-16","kind":"grant","acquired":true,"shares":6848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 16, 2019, the Company granted 6,848 shares of restricted stock (the \"Restricted Stock\") to the Reporting Person in lieu of a cash bonus. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests six months following the grant date."}],"balance_after":68308,"source":{"system":"sec-edgar","filing":"0000914190-19-000510","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419019000510/edgar.xml","form_type":"4"}},{"id":3368548,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Common Stock","published_at":"2019-11-18T12:13:18.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":750,"price":8.3756,"value":6281.7,"ownership":{"direct":true},"balance_after":61460,"source":{"system":"sec-edgar","filing":"0000914190-19-000417","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419019000417/edgar.xml","form_type":"4"}},{"id":3431202,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Common Stock","published_at":"2019-08-22T16:37:04.000Z","date":"2019-08-22","kind":"purchase","acquired":true,"shares":1500,"price":6.97,"value":10455.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.9675 to $6.9725. The reporting person undertakes to provide the Company, any security holder of the Company. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":60710,"source":{"system":"sec-edgar","filing":"0000914190-19-000337","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419019000337/edgar.xml","form_type":"4"}},{"id":3439990,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Stock Option (right to buy)","published_at":"2019-08-13T18:09:56.000Z","date":"2019-08-09","kind":"grant","acquired":true,"shares":9305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On 5/1/17, the Reporting Person was granted an option to purchase up to 46,525 shares of common stock of the Company. Options to purchase 5,815 shares vested on 5/1/18; options to purchase 17,447 shares vest quarterly in 12 equal amounts commencing on 7/1/18; options to purchase 4,655 shares will vest, if ever, on 2/1 following the Company's first completed fiscal year in which annual revenue exceeds $6,000,000; options to purchase 9,305 shares will vest, if ever, on 2/1 following the Company's first completed fiscal year in which annual revenue exceeds $10,000,000; and options to purchase 9,305 shares vested upon approval of listing of the Company's common stock on the Nasdaq Stock Market, New York Stock Exchange or such other national securities exchange approved by the Board."}],"balance_after":32567,"derivative":{"exercise_price":2.64,"expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":9305},"source":{"system":"sec-edgar","filing":"0000914190-19-000295","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419019000295/edgar.xml","form_type":"4"}},{"id":3439989,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Stock Option (right to buy)","published_at":"2019-08-13T18:09:56.000Z","date":"2019-08-09","kind":"grant","acquired":true,"shares":12880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On 2/13/17, the Reporting Person was granted an option to purchase up to 64,399 shares of common stock of the Company. Options to purchase 8,049 shares vested on 2/13/18; options to purchase 24,150 shares vest quarterly in 12 equal amounts commencing on 5/13/18; options to purchase 12,880 shares vested upon approval of listing of the Company's common stock on the Nasdaq Stock Market; options to purchase 6,440 shares will vest, if ever, on 2/1 following the Company's first completed fiscal year in which annual revenue exceeds $6,000,000; and options to purchase 12,880 shares will vest, if ever, on 2/1 following the Company's first completed fiscal year in which annual revenue exceeds $10,000,000."}],"balance_after":45079,"derivative":{"exercise_price":4.14,"expiration_date":"2027-02-13","underlying":"Common Stock","underlying_shares":12880},"source":{"system":"sec-edgar","filing":"0000914190-19-000295","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419019000295/edgar.xml","form_type":"4"}},{"id":3489710,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Common Stock","published_at":"2019-06-14T12:35:01.000Z","date":"2019-06-14","kind":"purchase","acquired":true,"shares":35000,"price":0.64,"value":22400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.62 to $0.65. The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 44,111 shares of restricted stock that vest on 6/14/19."}],"balance_after":532903,"source":{"system":"sec-edgar","filing":"0000914190-19-000213","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419019000213/edgar.xml","form_type":"4"}},{"id":3721398,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO/COO"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T16:54:56.000Z","date":"2018-12-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On 12/19/18, the Reporting Person was granted an option to purchase 200,000 shares of common stock of the Company. Options to purchase 50,000 shares vest on 12/19/19 and options to purchase 150,000 shares vest quarterly in 12 equal amounts commencing on 3/19/20."}],"balance_after":200000,"derivative":{"exercise_price":0.65,"expiration_date":"2028-12-19","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000914190-18-000586","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419018000586/edgar.xml","form_type":"4"}},{"id":3727216,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-18T17:34:32.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":44111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 14, 2018, the Company granted 44,111 shares of restricted stock (the \"Restricted Stock\") to the Reporting Person in lieu of a cash bonus. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests six months following the grant date."}],"balance_after":497903,"source":{"system":"sec-edgar","filing":"0000914190-18-000570","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419018000570/edgar.xml","form_type":"4"}},{"id":3934956,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants (right to buy)","published_at":"2018-05-14T16:44:37.000Z","date":"2018-05-14","kind":"other","acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":133333,"derivative":{"exercise_price":0.3,"exercise_date":"2017-03-17","expiration_date":"2022-03-17","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0000914190-18-000197","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419018000197/edgar.xml","form_type":"4"}},{"id":3934955,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-14T16:44:37.000Z","date":"2018-05-14","kind":"other","acquired":true,"shares":33333,"price":0.3,"value":9999.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 120,417 shares of restricted stock that vest on 6/20/18."}],"balance_after":453792,"source":{"system":"sec-edgar","filing":"0000914190-18-000197","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419018000197/edgar.xml","form_type":"4"}},{"id":3964800,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-04-12T16:11:29.000Z","date":"2018-04-10","kind":"purchase","acquired":true,"shares":80000,"price":0.45,"value":36000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 120,417 shares of restricted stock that vest on 6/20/18."}],"balance_after":420459,"source":{"system":"sec-edgar","filing":"0000914190-18-000137","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419018000137/edgar.xml","form_type":"4"}},{"id":3998552,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-13T16:08:56.000Z","date":"2018-03-09","kind":"purchase","acquired":true,"shares":5000,"price":0.475,"value":2375.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 120,417 shares of restricted stock (the \"Restricted Stock\") granted to the Reporting Person on December 20, 2017 in lieu of a cash bonus. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests six months following the grant date."}],"balance_after":340459,"source":{"system":"sec-edgar","filing":"0000914190-18-000121","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419018000121/edgar.xml","form_type":"4"}},{"id":4122556,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-12-22T11:31:34.000Z","date":"2017-12-20","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On 12/20/17, the Reporting Person was granted an option to purchase 50,000 shares of common stock of the Company.  25% of the shares subject to the option (relating to a total of 12,500 shares) vest on 12/20/18 and the remaining 75% of the shares subject to the option (relating to a total of 37,500 shares) vest quarterly in 12 equal amounts, commencing on 3/20/19."}],"balance_after":50000,"derivative":{"exercise_price":0.4999,"expiration_date":"2027-12-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000914190-17-000389","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419017000389/edgar.xml","form_type":"4"}},{"id":4122555,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-12-22T11:31:34.000Z","date":"2017-12-20","kind":"grant","acquired":true,"shares":120417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 20, 2017, the Company granted 120,417 shares of restricted stock (the \"Restricted Stock\") to the Reporting Person in lieu of a cash bonus. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests six months following the grant date."}],"balance_after":335459,"source":{"system":"sec-edgar","filing":"0000914190-17-000389","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419017000389/edgar.xml","form_type":"4"}},{"id":4142238,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-12-05T16:17:46.000Z","date":"2017-12-04","kind":"purchase","acquired":true,"shares":8333,"price":0.5,"value":4166.5,"ownership":{"direct":true},"balance_after":215042,"source":{"system":"sec-edgar","filing":"0000914190-17-000377","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419017000377/edgar.xml","form_type":"4"}},{"id":4142237,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-12-05T16:17:46.000Z","date":"2017-12-01","kind":"purchase","acquired":true,"shares":10000,"price":0.5,"value":5000.0,"ownership":{"direct":true},"balance_after":206709,"source":{"system":"sec-edgar","filing":"0000914190-17-000377","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419017000377/edgar.xml","form_type":"4"}},{"id":4223530,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-08-28T16:53:33.000Z","date":"2017-08-28","kind":"purchase","acquired":true,"shares":4000,"price":0.2729,"value":1091.6,"ownership":{"direct":true},"balance_after":196709,"source":{"system":"sec-edgar","filing":"0000914190-17-000261","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419017000261/edgar.xml","form_type":"4"}},{"id":4223529,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-08-28T16:53:33.000Z","date":"2017-08-28","kind":"purchase","acquired":true,"shares":6000,"price":0.27,"value":1620.0,"ownership":{"direct":true},"balance_after":192709,"source":{"system":"sec-edgar","filing":"0000914190-17-000261","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419017000261/edgar.xml","form_type":"4"}},{"id":4223528,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-08-28T16:53:33.000Z","date":"2017-06-16","kind":"other","acquired":true,"shares":43,"price":0.265,"value":11.395,"ownership":{"direct":true},"balance_after":186709,"source":{"system":"sec-edgar","filing":"0000914190-17-000261","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419017000261/edgar.xml","form_type":"4"}},{"id":4236656,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-08-11T17:35:18.000Z","date":"2017-08-11","kind":"purchase","acquired":true,"shares":20000,"price":0.2599,"value":5198.0,"ownership":{"direct":true},"balance_after":186666,"source":{"system":"sec-edgar","filing":"0000914190-17-000235","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419017000235/edgar.xml","form_type":"4"}},{"id":4321004,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-05-15T16:57:49.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":209355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On 5/1/17, the Reporting Person was granted an option to purchase up to 418,709 shares of common stock of the Company. 12.5% of the shares subject to the option (relating to a total of 52,339 shares) vest on 5/1/18; 37.5% of the shares subject to the option (relating to a total of 157,016 shares) vest quarterly in 12 equal amounts, commencing on 7/1/18; 10% of the shares subject to the option (relating to a total of 41,871 shares) will vest, if ever, on the February 1st following the Company's first completed fiscal year in which annual revenue exceeds (continued)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"$6,000,000; 20% of the shares subject to the option (relating to a total of 83,742 shares) will vest, if ever, on the February 1st following the Company's first completed fiscal year in which annual revenue exceeds $10,000,000; and 20% (relating to a total of 83,742 shares) will vest, if ever, upon approval of listing of the Company's common stock on the NASDAQ Stock Market, New York Stock Exchange or such other national securities exchange approved by the Board."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This amendment is being filed solely to correct the expiration date."}],"balance_after":209355,"derivative":{"exercise_price":0.293,"expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":209355},"source":{"system":"sec-edgar","filing":"0000914190-17-000153","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419017000153/edgar.xml","form_type":"4/A","original_submission_date":"2017-05-02"}},{"id":4338224,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-05-02T17:01:40.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":209355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On 5/1/17, the Reporting Person was granted an option to purchase up to 418,709 shares of common stock of the Company. 12.5% of the shares subject to the option (relating to a total of 52,339 shares) vest on 5/1/18; 37.5% of the shares subject to the option (relating to a total of 157,016 shares) vest quarterly in 12 equal amounts, commencing on 7/1/18; 10% of the shares subject to the option (relating to a total of 41,871 shares) will vest, if ever, on the February 1st following the Company's first completed fiscal year in which annual revenue exceeds (continued)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"$6,000,000; 20% of the shares subject to the option (relating to a total of 83,742 shares) will vest, if ever, on the February 1st following the Company's first completed fiscal year in which annual revenue exceeds $10,000,000; and 20% (relating to a total of 83,742 shares) will vest, if ever, upon approval of listing of the Company's common stock on the NASDAQ Stock Market, New York Stock Exchange or such other national securities exchange approved by the Board."}],"balance_after":209355,"derivative":{"exercise_price":0.293,"expiration_date":"2017-05-01","underlying":"Common Stock","underlying_shares":209355},"source":{"system":"sec-edgar","filing":"0000914190-17-000145","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419017000145/edgar.xml","form_type":"4"}},{"id":4376526,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants (right to buy)","published_at":"2017-03-21T17:52:58.000Z","date":"2017-03-17","kind":"purchase","acquired":true,"shares":166666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities have a purchase price of $0.30 per share of Common Stock. In addition, the reporting person received a Warrant to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock otherwise purchased. The reporting person purchased 166,666 shares of Common Stock and was issued a related Warrant to acquire up to 166,666 shares of Common Stock."}],"balance_after":166666,"derivative":{"exercise_price":0.3,"exercise_date":"2017-03-17","expiration_date":"2022-03-17","underlying":"Common Stock","underlying_shares":166666},"source":{"system":"sec-edgar","filing":"0000914190-17-000113","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419017000113/edgar.xml","form_type":"4"}},{"id":4376525,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-21T17:52:58.000Z","date":"2017-03-17","kind":"purchase","acquired":true,"shares":166666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities have a purchase price of $0.30 per share of Common Stock. In addition, the reporting person received a Warrant to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock otherwise purchased. The reporting person purchased 166,666 shares of Common Stock and was issued a related Warrant to acquire up to 166,666 shares of Common Stock."}],"balance_after":166666,"source":{"system":"sec-edgar","filing":"0000914190-17-000113","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419017000113/edgar.xml","form_type":"4"}},{"id":4445909,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":129432,"kind":"person","name":"Astor Andrew","position":1,"cik":"0001698052","reported_name":"Astor Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-15T16:27:57.000Z","date":"2017-02-13","kind":"grant","acquired":true,"shares":289785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On 2/13/17, the Reporting Person was granted an option to purchase up to 579,571 shares of common stock of the Company. 12.5% of the shares subject to the option (relating to a total of 72,446 shares) vest on 2/13/18; 37.5% of the shares subject to the option (relating to a total of 217,339 shares) vest quarterly in 12 equal amounts, commencing on 5/13/18; 20% of the shares subject to the option (relating to a total of 115,914 shares) will vest, if ever, upon approval of listing of the Company's common stock on the NASDAQ Stock Market, New York Stock Exchange or such other national securities exchange approved by the Board; 10% of the shares subject to the option (relating to a total of 57,957 shares) will vest, if ever, on the February 1st following the Company's first completed fiscal year in which annual revenue exceeds $6,000,000; (continued)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"and 20% of the shares subject to the option  (relating to a total of 115,914 shares) will vest, if ever, on the February 1st following the Company's first completed fiscal year in which annual revenue exceeds $10,000,000."}],"balance_after":289785,"derivative":{"exercise_price":0.4599,"expiration_date":"2027-02-13","underlying":"Common Stock","underlying_shares":289785},"source":{"system":"sec-edgar","filing":"0000914190-17-000055","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698052/000091419017000055/edgar.xml","form_type":"4"}}]}